Health Canada Approves IMFINZI® (durvalumab) for Previously Treated Patients with Advanced Bladder Cancer

By: Tom Eremondi Read time: 3.5 minutes Admittedly old school, Gerry Ross’ approach to dealing with a local walk sponsor nurtured and enhanced the relationship to a surprising level. This story, however, dates back aboutRead more

Read time: 2 minutes We were so pleased to see one of our new Peer Support Volunteers, Gervais  Fournier, featured in this New Normal, Same Cancer news story, seen last month in the Le JournalRead more

Subscribe today! Our May newsletter is filled with lots of initiatives to create awareness for bladder cancer including blogs, podcasts, helpful facts, webinars and more. Bladder cancer is the 5th most common cancer in Canada andRead more

Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way aboutRead more

(The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more

In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more

Spring has sprung and so has tax season! Don’t miss out on valuable credits or deductions! 

National Volunteer Week is celebrated annually to honour all the volunteers who make a powerful impact.

My life turned upside down with the announcement of a bladder cancer diagnosis.

Bladder Cancer Canada is thrilled to be hosting a special education event in Vancouver!

In May 2023, I noticed blood in my urine, which immediately raised concern. I visited my family doctor.